About Bioventrix IncLog in or Register to edit this
BioVentrix is a medical technology company that specializes in the development of less-invasive therapies for treating heart failure. The company's flagship product is the Revivent TC Transcatheter Ventricular Enhancement System, which is used to treat patients suffering from left ventricular dysfunction following a heart attack. The Revivent TC system is designed to reshape and restore the left ventricle to its optimal shape and size, which can improve cardiac function and reduce heart failure symptoms. BioVentrix is headquartered in San Ramon, California, and has operations in Europe and other regions.
Some competitors of BioVentrix in the field of medical technology for heart failure include:
1. Abbott Laboratories
3. Boston Scientific
4. Edwards Lifesciences
5. Cardiovascular Systems Inc.
7. Terumo Corporation
8. Abbott Vascular
9. St. Jude Medical
10. Sorin Group
These companies are also involved in the development and commercialization of various medical devices, treatments, and therapies for cardiovascular diseases, including heart failure.
The global market size for less-invasive therapies for treating heart failure was estimated to be around USD 3.7 billion and was expected to grow at a CAGR of 12.2% from 2021 to 2028. This includes the market for various less-invasive therapies such as transcatheter valve repair and replacement, left ventricular assist devices, and other minimally invasive devices and therapies for heart failure treatment.